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Background and Objective. The control of well-
known atherosclerotic risk factors represents the
optimal strategy in the prevention of acute coronary
syndromes. It was the aim of this work to analyze
the effects of a long-term cardiac rehabilitation pro-
gram on the changes of fibrinolysis parameters and
plasma lipid profile in coronary patients.
Design and Methods. The study was carried out in
30 (M/F:22/8, mean age 47 years) survivors of a
first acute myocardial infarction (AMI) and in 30
healthy controls who underwent a cardiac rehabili-
tation program (9 months duration). Samples were
taken before, at 3 and 9 months after the beginning
of the program to measure: tissue-type plasminogen
activator (t-PA) antigen and plasminogen activator
inhibitor (PAI-1) activity and antigen. A lipid profile
including cholesterol (both HDL and LDL) and lipo-
protein(a) was also assessed. The Wilcoxon and
Mann-Whitney tests were used for statistical com-
parisons.
Results. There was a marked decrease of function-
al PAI-1 after 3 and 9 months as compared with
baseline in AMI patients (p<0.01). Results showed
a significant increase of HDL-cholesterol (p<0.01)
and decrease of lipoprotein(a) levels after the exer-
cise program (p <0.01).
Interpretation and Conclusions. The cardiac reha-
bilitation program improved fibrinolysis, by reducing
the functional levels of PAI-1, and ameliorated the
lipid profile by decreasing lipoprotein(a) and increas-
ing HDL-cholesterol in patients with AMI. A long-
term cardiac rehabilitation has positive effects on
some risk factors for coronary disease.
©1998, Ferrata Storti Foundation
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Fibrin formation and subsequent thrombusgrowth at the site of atherosclerotic plaque dis-ruption is the most common cause of acute
coronary syndromes.1 Multiple interacting factors
are involved in the development of the atheroma
plaque, including disturbed lipid metabolism,
endothelial cell damage and disorders of the fibrin
balance with persisting fibrin deposits. Several
reports have evaluated the possible relationship
between deficient fibrinolysis and cardiovascular
processes, particularly coronary heart disease (CHD)
and atherosclerosis (reviewed in refs. #2-4). Fibri-
nolysis is the mechanism involved in fibrin degrada-
tion through the proteolytic action of the serine pro-
tease plasmin.5 This enzyme originates from the acti-
vation of the proenzyme plasminogen by tissue plas-
minogen activator (t-PA) released into the circula-
tion from the endothelium and rapidly inactivated by
the endothelial type plasminogen activator inhibitor
(PAI-1). Impaired fibrinolysis may result from either
low t-PA or elevated PAI-1 levels (reviewed in refs.
#4 and #6). Taking into account the potential link
between impaired fibrinolysis and CHD,7-10 the mod-
ification of the fibrinolytic system appears as an
attractive therapeutic approach. 
It is generally accepted that physical exercise
enhances the plasma fibrinolytic activity and induces
changes in some hemostatic parameters. An increase
in t-PA activity and decrease in PAI-1 and fibrinogen
levels have been described in healthy subjects fol-
lowing long-term exercise training.11,12 It has been
suggested that exercise could favorably influence the
clinical course of patients with coronary artery dis-
ease (CAD) through a reduction of PAI-1 levels.13,14
Evidence also accumulates indicating that exercise
might favorably modify several of the conventional
coronary heart disease risk factors including blood
lipids, obesity, blood pressure and insulin levels.15,16
The aim of this study was to evaluate the influence
of a rehabilitation sport program on the t-PA and
PAI-1 levels, as well on the lipid profile, in a group of
survivors of a first acute myocardial infarction (AMI).
Patients and Methods
Patients
Thirty consecutive outpatients (male/female: 22/8,
mean age 47 years) with confirmed myocardial infarc-
tion undergoing an exercise test were studied. Results
were compared with those obtained in 30 healthy
subjects (male/female: 19/11,  mean age 49 years)
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with no history of myocardial infarction, diabetes,
hypertension, obesity, smoking or medication use.
The Ethical Committee of the University Clinic of Navar-
ra approved the study protocol and oral informed
consent was obtained from all patients.
Exercise test
All subjects, patients and controls, followed a nine
month training program consisting of three weekly
sessions (40 minutes/session) where the maximal
oxygen uptake, aerobic and anaerobic thresholds
were assessed in maximal ergospirometry test using
an electrically braked bicycle ergometer. Subjective
(Borg scale) or objective (increase in oxygen con-
sumption less than 150 mL per minute despite of
increasing workload) tests were used as stopping cri-
teria for the exercise. The training program started
within a month from the diagnosis of AMI.
The maximal oxygen uptake was recorded in all
patients.
Biochemical analysis
The study was performed before starting the exercise
program and again 3 and 9 months after the begin-
ning of the study. Blood was drawn between 8.00 and
9.30 a.m. in patients and controls after 30 minutes
rest. Samples were collected by venipuncture from the
antecubital vein into 0.13 M trisodium citrate (9:1)
and centrifuged at 2000 g for 20 minutes at 4°C. Plas-
ma was immediately prepared by centrifugation and
kept on ice or frozen at –70°C until tested. 
Tissue-type plasminogen activator (t-PA) antigen
was determined with a commercially available mono-
clonal antibody based ELISA17 (TintElize t-PA, Biopool,
Sweden). PAI activity was measured by adding a certain
amount of t-PA to diluted plasma and assessing resid-
ual t-PA activity as previously described,18 using a com-
mercially available kit  (Coatest PAI, Chromogenix,
Stockholm, Sweden). Inhibitor activity was expressed
in units of t-PA  inhibited per mL. Plasminogen activa-
tor inhibitor-1 (PAI-1) antigen was measured by a
commercial ELISA (TintElize PAI-1, Biopool, Sweden)
basically following the method described by Declerck
et al.19 Lipoprotein(a) [Lp(a)] concentration was deter-
mined by enzymoimmunoanalysis  using a commer-
cially available ELISA kit  (Coaliza Lp(a), Chromogenix,
Sweden).20 Whole serum cholesterol and triglycerides
were measured by standard enzymatic methods. HDL-
cholesterol was measured in the supernatant after pre-
cipitation of apolipoprotein B-containing lipoproteins
with phosphotungstic acid and Mg++. LDL-cholesterol
was calculate according to the Friedewald’s formula.
Statistical analysis
Results are expressed as mean ± SD. Comparisons
of the levels before and after exercise test within each
group were performed by means of the Wilcoxon test
(paired values). Comparisons of the levels of the dif-
ferent parameters between control and IAM groups
were performed by means of the Mann-Whitney test.
Statistical significance was reached at p < 0.05.
Results
The study was carried out in 30 patients of both
sexes with a first AMI less than one month before
entering to the study. All patients were subjected to
a cardiac rehabilitation program during 9 months.
The control group consisted of 30 non-smokers, non-
obese and normotensive subjects without previous
history of coronary disease, who underwent the same
exercise program.
Baseline fibrinolytic activity and lipid profile
As shown in Table 1, a significant increase of t-PA
antigen and PAI-1 activity and antigen was observed
before exercise in the group of patients as compared
with the control group (p<0.01). As regards the lipid
profile (Table 2), there was a significant elevation of
total cholesterol (p<0.05), triglycerides (p<0.01) and
LDL-cholesterol (p<0.05)  in the patients group. A 3-
fold increase in Lp(a) levels was also demonstrated in
this group (138.2±71.8 mg/dL) as compared with
controls (43.8±21.8 mg/dL) (p<0.01). Levels of
HDL-cholesterol were also significantly reduced in
the patients group (p< 0.01).
Effects of physical exercise on  fibrinolysis
parameters
Whereas no significant differences in the t-PA lev-
els were observed in patients and controls at 3 and 9
months after the exercise program as compared to
baseline, we found a significant improvement of fib-
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Table 1. Fibrinolysis parameters before and after 3 and 9 months, respectively, the cardiac rehabilitation program. Mean±SD
is shown. 
Control Acute myocardial infarction
Parameter Basal 3 months 9 months Basal 3 months 9 months
t-PA antigen (ng/mL) 5.7±3.2 5.3±2.1 6.2±2.2 8.6±4.1° 7.7±2.3 9.1±3.7
PAI-1 activity (U/mL) 8.3±2.9 9.2±6.5 9.4±3.6 19.6±8.9° 12.8±6.2** 13.1±7.8**
PAI-1 antigen (ng/mL) 26.1±14.2 29.4±16.6 29.6±13.1 43.1±21.1° 37.7±12.7 36.9±12.5*
°p < 0.01 with respect to control; *p < 0.05 and **p < 0.01 with respect to values before exercise in both groups.
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rinolysis, via reduction of PAI-1 levels, in AMI
patients.
Figure 1 shows the behavior of PAI-1 activity and
antigen in patients and controls throughout the car-
diac rehabilitation program. There was a marked
decrease (p<0.01) of functional PAI-1 in AMI
patients (12.8±6.2 U/mL after 3 months and 13.1±
7.8 U/mL after 9 months as compared with baseline
value of 19.6±8.9 U/mL). Despite this reduction PAI-
1 activity levels still remained significantly higher at
the end of the program as compared to control val-
ues (p < 0.01). A tendency to a reduction in the anti-
gen levels was also observed at 3 months, being
slightly significant (p<0.05) 9 months after the begin-
ning of the program, although the levels remained
significantly higher (p<0.05) in relation to controls
(Figure 1). No differences in PAI-1 activity or antigen
could be detected throughout the program in the
control group.
A marked increase of maximal oxygen uptake was
observed in both groups 3 and 9 months after exer-
cise. The mean values in AMI patients ranged from 18
mL/kg/min before exercise to 22 mL/kg/min at 3
months (p<0.001) and 23 mL/kg/min at  9 months
(p<0.001).
Other biochemical changes induced by physical
exercise
The evolution of the different lipid measurements
in control group and AMI patients throughout the
rehabilitation program is shown in Table 2. A signif-
icant increase in plasma HDL-cholesterol was
observed in the AMI patients after 3 (p<0.05) and 9
months (p<0.01) of exercise as compared with base-
line values.  That increase was also present in the con-
trol group after 9 months. On the other hand, as
shown in Figure 2, physical exercise induced a marked
decrease (p<0.01) in the Lp(a) concentration in the
AMI group, both 3 and 9 months after the cardiac
rehabilitation program, whereas a slight decrease was
observed in the control group at 9 months without
reaching statistical significance. However, the Lp(a)
levels still remained significantly enhanced and HDL-
cholesterol concentrations more reduced in the
group of patients at the end of the program as com-
pared to control values (p<0.01).
Discussion
We have evaluated the effects of an exercise test on
the t-PA and PAI-1 levels as well as on the lipid pro-
file in a group of patients with CHD. The major find-
ings of this study are that a long-term cardiac reha-
bilitation program improves fibrinolysis by reducing
the functional levels of PAI-1, and reduces the Lp(a)
concentrations while increasing HDL-cholesterol in
patients with AMI.
Epidemiological and clinical studies have revealed
a positive association of impaired fibrinolysis due to
abnormally high levels of PAI-1 not only with the
extent of CHD but also with the appearance of rein-
farction in AMI survivors.9,10,21 In aggregate, impaired
fibrinolysis resulting from increased plasma or plaque
PAI-1 might contribute to the development and/or
progression of atherosclerosis by promoting throm-
bosis or matrix deposition.2,3 Finally, in situ analysis
of the atherosclerotic plaque also revealed increased
expression of PAI-1.22
We, therefore, tried to analyze whether a long-term
cardiac rehabilitation program would be able to
modify the impaired fibrinolysis. In this study signif-
icant fibrinolysis abnormalities as a consequence of
increased t-PA antigen and PAI- 1 activity and anti-
gen levels were observed in the AMI patients before
entering the cardiac rehabilitation program, in agree-
ment with previous reports (reviewed in refs. #4 and
6). However, we found a significant reduction in PAI-
1 activity after regular long-term (9 months duration)
physical exercise indicating that this training program
had beneficial effect on fibrinolysis. Nevertheless,
PAI-1 levels did not reach the values observed in the
control group, suggesting that the exercise program
was not able to completely improve the impaired fib-
rinolytic response in AMI patients. Similar results
were reported by Speiser et al.23 in individuals with
different sporting activities and Estellés et al.,14,24 after
an ergometric test performed 3 and 6 months after
AMI. According to our results it is unlikely that a
longer term program could further improve the fibri-
Effects of exercise on lipids and fibrinolysis
Table 2. Influence of physical exercise on lipid profile in patients and controls. Values represent the mean±SD. 
Control Acute myocardial infarction
Parameter Basal 3 months 9 months Basal 3 months 9 months
Cholesterol (mg/dL) 198.9±24.5 202.3±33.9 205.6±37.1 227.7±43.1° 212.7±33.3 221.6±36.3
Tryglicerides (mg/dL) 72.8±29.2 69.1±24.9 73.4±55.8 153.2±60.3°° 136.6±87.8 131.1±93.7
HDL-cholesterol (mg/dL) 47.1±10.8 50.1±11.8 58.5±14.7** 30.9±9.1°° 35.5±11.3* 40.2±9.7**
LDL-cholesterol (mg/dL) 136.8±20.6 140.9±31.7 139.6±27.1 156.7±44.1° 151.1±32.8 158.7±33.7
Lipoprotein(a)  (mg/dL) 43.8±21.8 35.4±19.5 28.9±13.6 138.2±71.8°° 90.4±75.1** 86.3±80.6**
°p < 0.05 and °° p < 0.01 with respect to control; *p < 0.05 and **p < 0.01 with respect to values before exercise in both groups.
nolytic potential in AMI patients.
Although it is generally accepted that physical exer-
cise improves fibrinolytic activity in healthy people11,25
and in series of patients with CHD,14,23 we did not
observe significant changes in the t-PA antigen levels.
There are conflicting results as regards to the exer-
cise-induced changes on fibrinolysis, reporting the
resting fibrinolytic activity increases, decreases or
remains unchanged.26-30 It has also been reported
that intensive physical exercise in postinfarction
patients may actually lead to increased clotting ten-
dency.31 The great diversity of results is due to the
wide variation in training regimens, the differences in
the clinical characteristics of patients included, and
the methodology applied. 
Whereas the reason for the PAI-1 reduction after
exercise is not completely understood, the observed
increase in the maximal oxygen uptake at 3 and 9
months after the physical training seems to be rele-
vant to explain such reduction. Physical training,
which increases liver blood flow, induces the release
of t-PA and improves insulin sensitivity would favor
reduced PAI-1 synthesis.30 On the other hand, since
CHD is associated with endothelial dysfunction and
altered vascular endothelium generates abnormally
higher PAI-1 levels, it could be speculated that phys-
ical exercise would improve endothelial function in
patients with CHD.32 It is unlikely that PAI-1 reduc-
tion could be ascribed exclusively to the resolution of
the acute-phase phenomenon, since we and others
have demonstrated that PAI-1 remains elevated
months after the acute episode,9,33 which rules out
the possibility that the observed changes could be
exclusively attributed to a time-related phenomenon.
When considering the exercise-induced changes in
the lipid profile in the studied population we
observed increased levels of HDL-cholesterol and a
reduction in the plasma Lp(a) concentration, sug-
gesting an additional beneficial effect in AMI through
lipid modification. 
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Figure 1. PAI-1 activity (top) and antigen (bottom) in control
group and AMI patients before and 3 and 9 months after the
cardiac rehabilitation program. Mean ± SEM is shown. 
*p<0.05 and **p<0.01 with respect to values before exer-
cise.
Figure 2. Lipoprotein(a) levels (top) and HDL-cholesterol (bot-
tom) in the control group and AMI patients before and 3 and
9 months after the cardiac rehabilitation program. Mean ±
SEM is shown. *p<0.05 and **p<0.01 with respect to values
before exercise.
PAI-1 antigen
PAI-1 activity
Months
Months
MonthsMonths
ng/mL
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Whereas several reports have shown high Lp(a) lev-
els as a powerful risk factor for coronary disease,34,35
epidemiological studies suggest that regular physical
exercise may reduce cardiovascular risk through a
modification of several of the coronary risk factors
including blood lipids.15,16 However, studies analyzing
the influence of physical exercise on plasma lipid con-
centrations in healthy subjects and CHD patients
have given contradictory results.36,37 A recent report
exploring the relationship of exercise to Lp(a) levels in
patients with insulin-dependent diabetes mellitus
showed that physical fitness, measured by V02 max
during bicycle ergometer, correlated inversely with
Lp(a), suggesting that it may decrease the risk of
CHD through modulating lipid levels.38
An interesting but unresolved issue is whether the
atherothrombotic activity of Lp(a) might be attrib-
uted at least in part to an inhibitory role on plasmin
formation, by competing with plasminogen for the
binding to fibrin.39 From our results it can be specu-
lated that the significant  Lp(a) decrease observed in
the AMI group 3 and 9 months after the rehabilitation
program would facilitate the binding of plasminogen
to fibrin thus accelerating the plasmin generation rate.
Whether a reduction in Lp(a) level is associated with
a reduction in cardiovascular events, as reported with
cholesterol-lowering therapy, has not yet been deter-
mined. Finally, our results confirm previous studies
showing that exercise is associated with an increase in
HDL-cholesterol, thus improving lipid metabolism.40,41
Taking all these data together it could be specu-
lated that a controlled cardiac rehabilitation training
program ameliorates both PAI-1 and blood lipid
composition in coronary patients, possibly through
changes in insulin sensitivity and body fat mass.42,43
In conclusion, our results strongly indicate that the
maintenance of a regular physical exercise program
has a beneficial effect in AMI patients by improving
both thrombogenic and atherogenic risk factors for
coronary disease. Future studies should address the
ability of exercise training to modify fibrinolytic vari-
ables in other cardiovascular groups and whether
other training protocols are capable of improving
more significantly the altered fibrinolysis in patients
with coronary disease, since despite the exercise-
induced improvement, both PAI-1 and Lp(a) still
remained above the normal values.
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